News from the global pharmaceuticals industry about head lice treatments and corporate developments, including takeovers and mergers.
Tyratech, Inc. has recently announced two further US distribution agreements for Vamousse, its lice treatment product.
Hatchtech recently announced plans to commercialise its Xeglyze lice treatment product, while Ego Pharmaceuticals expand their international distribution network.
Several head lice companies have recently released financial updates related to their head lice treatments.
Tyratech have announced increased sales for the Vamousse head lice treatment, and are extending their distribution network in both the US and the UK.
A new treated coat-stand is being trialled in France, aiming to reduce the spread of head-lice in schools.
A summary of recent pediculosis product news.
Two companies producing market-leading head lice products have released recent trading updates.
Tyratech, inc last week announced a successful share offering along with deals for distribution of its head lice products with UK chemist chains.
TyraTech Inc recently announced that their VaMOUSSE! range of head lice products are available to purchase online in the United States.